CLINICAL_TRIALS
trial_result
· 2013-03-19
Clinical Trial Update: Erythropoietin in the Prevention of Acute Mountain Sickness [Phase 4]
Summary
A Phase 4 clinical trial evaluated erythropoietin for the prevention of Acute Mountain Sickness; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Ulsan | Conditions: Acute Mountain Sickness | Phase 4 | Status: COMPLETED